| Synonyms: | |
| Status: | Phase 2 |
| Entry Type: | Small molecule |
| Molecule Category: | UNKNOWN |
| UNII: | 8HO6PVN24W |
| InChI Key | CQOVPNPJLQNMDC-ZETCQYMHSA-N |
|---|---|
| Smile | |
| InChI |
|
| Property Name | Value |
|---|---|
| Molecular Formula | C9H14N4O3 |
| Molecular Weight | 226.24 |
| AlogP | -1.13 |
| Hydrogen Bond Acceptor | 4.0 |
| Hydrogen Bond Donor | 4.0 |
| Number of Rotational Bond | 6.0 |
| Polar Surface Area | 121.1 |
| Molecular species | ZWITTERION |
| Aromatic Rings | 1.0 |
| Heavy Atoms | 16.0 |
| Targets | EC50(nM) | IC50(nM) | Kd(nM) | Ki(nM) | Inhibition(%) | |
|---|---|---|---|---|---|---|
|
Transporter
Electrochemical transporter
SLC superfamily of solute carriers
SLC21/SLCO family of organic anion transporting polypeptides
|
- | - | - | - | 26 |
| Mesh Heading | Maximum Phase | Mesh ID | Reference |
|---|---|---|---|
| Schizophrenia | 2 | D012559 | ClinicalTrials |
| Peripheral Arterial Disease | 2 | D058729 | ClinicalTrials |
| Persian Gulf Syndrome | 2 | D018923 | ClinicalTrials |
| Resources | Reference |
|---|---|
| ChEBI | 15727 |
| ChEMBL | CHEMBL242948 |
| DrugBank | DB11695 |
| EPA CompTox | DTXSID80879594 |
| FDA SRS | 8HO6PVN24W |
| Human Metabolome Database | HMDB0000033 |
| Guide to Pharmacology | 4559 |
| KEGG | C00386 |
| PDB | 8V0 |
| SureChEMBL | SCHEMBL33769 |
| ZINC | ZINC000002040854 |